Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Last time I owned this, was when I sold it over $70, really dodged a bullet on this one.. unfortunately I own MNMD.. and it’s just as bad of a fall down shit show
Definitely overpriced. Government needs slaves. No way they'll let humanity awaken
Are you peeps watching PSYCF? I definitely think it's going to become the LEADER and Catalyst for the Mushroom sector!
Best mushroom play is PSYCF!!! Pay Attn.
.PSYCF
.
Awesome mushroom video & sound
With its iconic red cap & white spots, our mushroom is the most recognizable mushroom in pop culture. It's often pictured in children's books, creating an association with magic and fairies, and tales told about the mushroom evoke an inner journey to the psyche.$PSYC $PSYC.C pic.twitter.com/XPTZXGY09C
— Psyched Wellness (@PsychedWellness) January 5, 2022
Psychedelics are very safe drugs. A long term remission in treatment resistant major depression is a highly valuable and rare benefit to achieve for these patients.
On occasion there are reported cases of a psychosis induced, usually when that happens it is on very large doses of psychedelics perhaps combined with a non supportive environment.
Psilocybin causes fewer of these outcomes I have heard and is perhaps a less intense experience. Psilocybin is known to be a shorter acting psychedelic than LSD is.
Sedatives such as Valium or Xanax should be available if needed or desired at the end of the session in my opinion. Otherwise the process of coming down from the peak experience can be a drawn out and somewhat unpleasant process.
I love this stock!! Just flipped this for a $1500 profit in 24 hrs..
The clinical study for Treatment Resistant Major Depression looked very successful. Can a psychiatrist prescribe this patented psilocybin similar to how cannabis is illegal but medical doctors recommend it’s use legally for medical dispensaries?
How are they able to patent a known plant chemical? They claim to have a patented form of psilocybin.
This stock has really come back nicely!!
Awesome, just made $7700 on this trade!!!
Steady increases, looks like we can get past $40 and then maybe $50?
Sure was.
Schroom pharma is really advancing.
Nice interview. Now that ketamine therapy is in use, I really don't see any significant roadblocks to further expansion into other drugs.
Execution will be critical, plus how many competitors end up in the space.
I can't think of a better speculative space right now!
GLTA!
Tiny, tiny position today:
10 shares @35.
Nice spec.
MY OPINION ONLY.
NEW BOARD!!! Psychedelic Stocks (link here)
https://investorshub.advfn.com/Psychedelic-Stocks-39490/
I've eyeballed CMPS but not new to shroom stocks. What's the deal with this. Clinicaltrials.gov trial for treatment resistant depression in may ? Is that right?
Could this we thousands dollar stock lollllll
***PR OUT***
COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences
London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management team will participate in two investor conferences during the week of 11 January 2021.
George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will be participating in a fireside chat available on demand from 11 to 14 January in conjunction with the HC Wainwright BioConnect 2021 Conference.
George Goldsmith and Lars Wilde will also present a business update and hold a fireside chat at 12:15 pm ET on 14 January at the Westwicke Healthcare Day at the ICR Conference 2021.
Audio webcasts of the fireside chats will be available on the "Events" page of the Investors section of the COMPASS website at https://ir.compasspathways.com/news-events/events. A replay of events will be available for 30 days following the event.
https://www.globenewswire.com/news-release/2021/01/06/2154099/0/en/COMPASS-Pathways-plc-to-participate-in-HC-Wainwright-and-ICR-investor-conferences.html
CMPS has $196.5 MILLION in cash (as of 30 Sep 2020)
That should hold them for about 4 years at the current burn rate of about $50 million per year.
https://sec.report/Document/0001628280-20-016249/
Anxiety depression drug companies.
1.VTGN market cap $150 million 115 million in cash has Phase 3 & Phase 2's (Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
2 $CMPS2.0 BILLIION early trials 180 million cash
3 $MMED 1.1 BILLION phase 2 raised 40 million in cash
4 $SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline
$CMPS
CMPS on the road to $100 woohooooooooo
I am in this and MMEDF. Both of these are the horses.
CMPS
OREGON legal.PSILOCIBIN WILL BE LEGAL THIS YEAR.
RUMOR IS OUT
PAYPAL ceo is buying more here
If you're watching $CMPS, you've gotta take a look at $SILO https://alphastocknews.com/silo-pharma-silo-stock-to-climb-on-planned-clinical-trial/4880/
You are a smart man
CMPS $60 TARGET PRICE WOOHOOOOOOOOOOOOOOO
CMPS is cool but are they actually selling the psychedelic mushroom or truffle?
https://www.newswire.ca/news-releases/red-light-holland-and-halo-labs-announce-intention-to-enter-oregon-medicinal-psilocybin-market-865973588.html
Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market
www.halocanna.com (CNW Group/Halo Labs Inc.)
News provided by
Halo Labs Inc.
Nov 19, 2020, 20:14 ET
Share this article
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
TORONTO, Nov. 19, 2020 /CNW/ - Halo Labs Inc. ("Halo") (NEO: HALO) (OTC: AGEEF) (Germany: A9KN) and Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland") are pleased to announce they have entered into a non-binding letter of intent for the purposes of creating a joint venture to become a licensed psilocybin manufacturer to supply psilocybin products to licensed service centers in the State of Oregon, and to explore other potential business opportunities in this new regulated market, subject to compliance with all applicable Oregon laws and regulations.
"Clearly, we are very excited with the recent results of Oregon Measure 109 where progressive Oregonians have voted in favor of becoming the first state in the US, to allow the use of psilocybin, for therapeutic use. We take pride at Red Light Holland in our self-regulated responsible adult use psilocybin legal product (iMicrodose packs in the Netherlands), which we feel could become a model for the development of psilocybin products for the Oregon regulated market to be used to potentially treat chronic mental health issues like anxiety, depression, and addiction" said Red Light Holland CEO and Director Todd Shapiro. "We are aware that these are early days for the Oregon psilocybin market, we cannot make medical claims, and the path ahead is still a long one as the Oregon Health Authority still has to create a state-licensed, psilocybin-assisted therapy program over the next two years. This is exactly why we have entered into a non-binding LOI with Halo Labs, as CEO Kiran Sidhu and his team have deep regulatory experience and relationships with Oregon lawmakers and state officials, having founded Halo Labs, a successful vertically integrated cannabis company that started in the State of Oregon and now operates in multiple US states, Africa and in the UK" added Shapiro.
"We believe we are in a great position to work closely with Oregon regulatory authorities with respect to the implementation of Measure 109 and the development of Oregon's regulatory psilocybin regime," said Kiran Sidhu, CEO of Halo. "We are delighted to be working with Todd Shapiro and the team at Red Light Holland, as they have the experience, know-how and the right viewpoint with their educational, informational, innovative, and careful perspective on access to psilocybin. We are looking forward to taking the next steps in second half of 2021 in this emerging market together. We remain exclusively focused on cannabis in Oregon and see medical psilocybin as a longer term opportunity."
Further details of the proposed joint venture will be announced once available and as the contours of the Oregon regulated market begin to take shape.
About Halo Labs
Halo is a leading, vertically-integrated cannabis company that cultivates, extracts, manufactures and distributes quality cannabis flower, oils, and concentrates, and has sold approximately six million grams of oils and concentrates since inception. Halo continues to scale efficiently, partnering with trustworthy leaders in the industry, who value their operational expertise in bringing top-tier products to market. Current growth includes expansion in key markets in the United States, United Kingdom and Africa, with planned geographic expansion into Canadian markets. With a consumer-centric focus, Halo markets value-driven, branded, and private-label products across multiple product categories. The Company also has acquired a range software development assets, such as the technology platforms CannPOS, Cannalift, and more recently signed a deal to acquire CannaFeels. Halo also owns the inhalation technology, Accudab.
Halo is led by a strong, diverse and innovative management team, with deep industry knowledge and blue-chip experience. The Company is currently operating in the United States throughout California, Oregon, and Nevada. Notably, The Company has signed a definitive agreement to acquire Winberry Farms which provides another acre of cultivation to add to the existing 6 acres Halo already owns and/or manages in Oregon, which further solidifies the Company's supply chain and increases its variety of cannabis strains. Internationally, the Company is currently cultivating cannabis at Bophelo Bioscience & Wellness (Pty) Ltd, in Lesotho and has acquired CBPM importation and distribution licensing in the United Kingdom via cannabis supplier, Canmart.
For further information regarding Halo, see Halo's disclosure documents on SEDAR at www.sedar.com
About Red Light Holland Corp.
Red Light Holland is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Cautionary Note Regarding Forward-Looking Information and Statements
Neither the Canadian Securities Exchange (the "CSE") nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Red Light Holland and Halo's control.
Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward- looking statements contained herein include, but are not limited to, information the timing and other aspects of the non-binding letter of intent with Halo Labs, and the proposed joint venture. Although each of Red Light Holland and Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward- looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that the joint venture with will proceed, or if it does proceed it will reflect the understanding of the parties as of the date of this release. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
Followers
|
25
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
75
|
Created
|
10/23/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |